Although overall SPP1 levels are higher in human PCa BM samples from GSE74685, two distinct subpopulations of bone-metastatic PCa patients were identified with high and low SPP1 expression (Fig. 4A), reflecting inter-patient PCa heterogeneity [12, 32]. This evidence concerns the gene SPP1 and posterior cortical atrophy.